What's new in the treatment of non-alcoholic fatty liver disease (NAFLD)

M Kosmalski, R Frankowski, S Ziółkowska… - Journal of Clinical …, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is a serious health problem due to its high
incidence and consequences. In view of the existing controversies, new therapeutic options …

A systematic review and meta-analysis of the effects of Hibiscus sabdariffa on blood pressure and cardiometabolic markers

LR Ellis, S Zulfiqar, M Holmes, L Marshall… - Nutrition …, 2022 - academic.oup.com
Context Hibiscus sabdariffa (hibiscus) has been proposed to affect cardiovascular risk
factors. Objective To review the evidence for the effectiveness of hibiscus in modulating …

D-Carvone Attenuates CCl4-Induced Liver Fibrosis in Rats by Inhibiting Oxidative Stress and TGF-ß 1/SMAD3 Signaling Pathway

HA Ogaly, SAA Aldulmani, FAM Al-Zahrani… - Biology, 2022 - mdpi.com
Simple Summary Liver fibrosis is a challenging global health problem resulting in a
significant morbidity and mortality rates worldwide due to its rapid progression to cirrhosis …

Functional foods and dietary supplements in the management of non-alcoholic fatty liver disease: A systematic review and meta-analysis

L Wang, P Zhang, H Yan - Frontiers in Nutrition, 2023 - frontiersin.org
Objective In this systematic review and meta-analysis, we aimed to clarify the overall effects
of functional foods and dietary supplements in non-alcoholic fatty liver disease (NAFLD) …

Therapeutic actions of tea phenolic compounds against oxidative stress and inflammation as central mediators in the development and progression of health problems …

H Liu, H Guan, F He, Y Song, F Li… - Critical Reviews in …, 2024 - Taylor & Francis
Many health problems including chronic diseases are closely associated with oxidative
stress and inflammation. Tea has abundant phenolic compounds with various health …

Exploring the impact of nutrition on non-alcoholic fatty liver disease management: unveiling the roles of various foods, food components, and compounds

M Kosmalski, R Frankowski, K Deska… - Nutrients, 2023 - mdpi.com
There is a need to introduce standardized treatment options for non-alcoholic fatty liver
disease (NAFLD) due to its global prevalence and the complications of this disease. Many …

[HTML][HTML] Efficacy and Safety of Hibiscus sabdariffa in Cardiometabolic Health: An Overview of Reviews and Updated Dose-Response Meta-Analysis

M Norouzzadeh, MH Rashedi, MH Azizi… - … Therapies in Medicine, 2025 - Elsevier
Background Conventional treatments for cardiometabolic diseases face limitations related to
cost, efficacy, and side effects. Hibiscus sabdariffa (HS) is a common food product and a …

Nutritional supplementation for nonalcohol‐related fatty liver disease: a network meta‐analysis

O Komolafe, E Buzzetti, A Linden… - Cochrane Database …, 2021 - cochranelibrary.com
Background The prevalence of non‐alcohol‐related fatty liver disease (NAFLD) varies
between 19% and 33% in different populations. NAFLD decreases life expectancy and …

[HTML][HTML] Evaluating Bioactive-Substance-Based Interventions for Adults with MASLD: Results from a Systematic Scoping Review

D Handu, K Stote, T Piemonte - Nutrients, 2025 - mdpi.com
Objective: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a chronic
condition affecting a broad population. This review aimed to identify and summarize the …

Evidence on the use of alternative substances and therapies in hypertension

E Martín-Riobóo, M Turégano-Yedro… - Hipertensión y Riesgo …, 2024 - Elsevier
Objective Review of some of the best-known biological and non-biological complementary/
alternative therapies/medicines (CAM) and their relationship with blood pressure (BP) and …